NDC 51672-2144-01 - Ibuprofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-2144
- Requested NDC
- 51672-2144-01
- Package NDCs from labels
- 51672-2144-8, 51672-2144-1, 51672-2144-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.
- Effective date
- 2025-07-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ibuprofen | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-07-07 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-2144-1 | Ibuprofen | 240 mL in 1 BOTTLE | SUSPENSION | 240 | 5 | |
| 51672-2144-1 | Ibuprofen | 1 in 1 CARTON | SUSPENSION | 1 | 5 | |
| 51672-2144-8 | Ibuprofen | 120 mL in 1 BOTTLE | SUSPENSION | 120 | 5 | |
| 51672-2144-8 | Ibuprofen | 1 in 1 CARTON | SUSPENSION | 1 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-2144 | IBUPROFEN SUSPENSION [-SUN PHARMACEUTICAL INDUSTRIES, INC.] | 4 | Current NDC, Legacy NDC, 4 package rows | 20250406_6cf3328b-da8f-4f6b-8237-16a4d6b9c833.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| childrens ibuprofen | IBUPROFEN | H E B | e7e2b766-6d05-49e2-9e88-72454b857935 | 2019-12-27 | Warnings | 197803 WK2XYI10QM |
| Renacidin | CITRIC ACID, GLUCONOLACTONE AND MAGNESIUM CARBONATE | United-Guardian, Inc. | 13a9bbba-db21-4cba-991c-5d8afaf2ed74 | 2019-12-17 | Warnings, Adverse reactions | XF417D3PSL |
| Ibuprofen 200mg | IBUPROFEN 200MG | Allegiant Health | 2e33a153-0a3f-4b88-b193-d63e0b792ccc | 2019-12-12 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PuraCap Pharmaceutical LLC | 73eb763e-ce21-4cff-854f-3297f20f1f61 | 2019-12-10 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PuraCap Pharmaceutical LLC | 40501966-419a-4ccd-b7c9-5581cbe47a97 | 2019-12-10 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PuraCap Pharmaceutical LLC | b6e14f73-1f19-4cfa-8858-136a38ee32d0 | 2019-12-10 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PuraCap Pharmaceutical LLC | 67e09ad5-e010-4aa1-b86e-9b22331bf33b | 2019-12-10 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PuraCap Pharmaceutical LLC | 24ef6819-f098-4d01-bfe7-6ffa4aa0e671 | 2019-12-10 | Warnings | WK2XYI10QM |
| Congestion Relief | IBUPROFEN, PHENYLEPHRINE HCL | Meijer Distribution Inc | 84f932b6-0aee-4cf9-b4b9-213560c42c1d | 2019-12-05 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd | 50bab3b2-f710-46ff-96cd-1ec4d4658529 | 2019-11-22 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd | f42506f7-896c-47a9-a4b1-ed72434d7aa0 | 2019-11-22 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd | 58bff8bf-5a4e-4390-9c03-e266d31deb6b | 2019-11-22 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd | daf579dc-91d1-4950-b637-c1a34f5542c5 | 2019-11-22 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Sam's West, Inc. | 90c301ad-7bbd-4e21-8054-35596b208cd4 | 2019-11-21 | Warnings | WK2XYI10QM |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | e41adb4e-06fb-4141-ba55-50b043f3c9da | 2019-11-19 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 14445dfd-6041-40cd-a043-3f4da6bcb9c1 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 2557199a-5f60-49d8-b093-1e0700211243 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 794f724c-87f0-49c1-9b26-c9e491978313 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 5c7d3287-883a-459b-9214-074a583c8a59 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 448a1dc5-7a98-4b2f-82af-4b92de05cfc3 | 2019-11-18 | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.